Primary |
Hiv Infection |
38.4% |
Product Used For Unknown Indication |
15.4% |
Drug Use For Unknown Indication |
14.7% |
Drug Exposure During Pregnancy |
13.0% |
Maternal Exposure Timing Unspecified |
4.6% |
Antiretroviral Therapy |
4.2% |
Acquired Immunodeficiency Syndrome |
1.1% |
Hypertension |
0.9% |
Hiv Test Positive |
0.9% |
Antifungal Prophylaxis |
0.9% |
Maternal Exposure During Pregnancy |
0.9% |
Systemic Antiviral Treatment |
0.8% |
Antiviral Treatment |
0.7% |
Insomnia |
0.6% |
Diffuse Panbronchiolitis |
0.6% |
Hepatitis C |
0.5% |
Prophylaxis |
0.5% |
Factor Viii Deficiency |
0.4% |
Mycobacterium Avium Complex Infection |
0.4% |
Gastritis |
0.4% |
|
Abortion Spontaneous |
14.6% |
Drug Exposure During Pregnancy |
12.3% |
Vomiting |
9.0% |
Premature Baby |
7.9% |
Foetal Exposure During Pregnancy |
6.7% |
Weight Decreased |
4.6% |
Abortion Induced |
3.9% |
Umbilical Cord Abnormality |
3.9% |
Nausea |
3.8% |
Stillbirth |
3.6% |
Weight Increased |
3.6% |
Renal Failure |
3.3% |
Lymphoma |
3.0% |
Meningitis Cryptococcal |
3.0% |
Thrombocytopenia |
3.0% |
Viral Load Increased |
3.0% |
Renal Failure Acute |
2.8% |
Trisomy 21 |
2.8% |
Diarrhoea |
2.6% |
Maternal Exposure During Pregnancy |
2.6% |
|
Secondary |
Hiv Infection |
67.1% |
Product Used For Unknown Indication |
6.0% |
Drug Use For Unknown Indication |
5.4% |
Antiretroviral Therapy |
4.6% |
Acquired Immunodeficiency Syndrome |
3.3% |
Antiviral Treatment |
2.4% |
Drug Exposure During Pregnancy |
2.1% |
Hypertension |
1.2% |
Hiv Test Positive |
1.0% |
Hepatitis C |
1.0% |
Prophylaxis |
0.9% |
Antifungal Prophylaxis |
0.9% |
Depression |
0.8% |
Diabetes Mellitus |
0.5% |
Factor Viii Deficiency |
0.5% |
Insomnia |
0.5% |
Opportunistic Infection Prophylaxis |
0.5% |
Tuberculosis |
0.4% |
Trigeminal Neuralgia |
0.4% |
Maternal Exposure Timing Unspecified |
0.3% |
|
Pregnancy |
9.7% |
Vomiting |
9.3% |
Renal Failure Acute |
9.1% |
Drug Exposure During Pregnancy |
7.4% |
Myocardial Infarction |
6.6% |
Premature Baby |
5.8% |
Renal Colic |
5.8% |
Thrombocytopenia |
4.3% |
Osteonecrosis |
4.1% |
Umbilical Cord Abnormality |
3.9% |
Renal Impairment |
3.8% |
Rash |
3.7% |
Maternal Exposure During Pregnancy |
3.5% |
Renal Failure |
3.5% |
Stillbirth |
3.5% |
Abortion Spontaneous |
3.4% |
Weight Decreased |
3.4% |
Weight Increased |
3.3% |
Diabetes Mellitus |
3.0% |
Gastrointestinal Malformation |
3.0% |
|
Concomitant |
Hiv Infection |
67.1% |
Product Used For Unknown Indication |
7.3% |
Drug Use For Unknown Indication |
4.5% |
Hepatitis C |
3.6% |
Acquired Immunodeficiency Syndrome |
3.5% |
Depression |
1.6% |
Prophylaxis |
1.5% |
Hypertension |
1.5% |
Hiv Test Positive |
1.4% |
Antiretroviral Therapy |
1.2% |
Drug Exposure During Pregnancy |
1.2% |
Pain |
1.0% |
Insomnia |
0.8% |
Antifungal Prophylaxis |
0.7% |
Anxiety |
0.7% |
Mycobacterium Avium Complex Infection |
0.6% |
Hyperlipidaemia |
0.6% |
Diabetes Mellitus |
0.5% |
Factor Viii Deficiency |
0.4% |
Nausea |
0.4% |
|
Vomiting |
9.2% |
Abortion Spontaneous |
8.1% |
Rash |
6.9% |
Renal Failure Acute |
6.6% |
Pyrexia |
6.1% |
Weight Decreased |
5.6% |
Renal Failure |
5.3% |
Myocardial Infarction |
5.1% |
Death |
4.9% |
Anaemia |
4.8% |
Thrombocytopenia |
4.8% |
Nephrolithiasis |
4.7% |
Pregnancy |
4.5% |
White Blood Cell Count Decreased |
4.2% |
Renal Colic |
3.8% |
Weight Increased |
3.8% |
Renal Tubular Disorder |
3.2% |
Premature Baby |
3.1% |
Renal Impairment |
2.7% |
Stillbirth |
2.6% |
|
Interacting |
Hiv Infection |
48.9% |
Product Used For Unknown Indication |
12.4% |
Infection |
10.4% |
Drug Use For Unknown Indication |
8.6% |
Hiv Test Positive |
2.9% |
Antiretroviral Therapy |
2.4% |
Acute Myocardial Infarction |
2.0% |
Chemotherapy |
1.6% |
Herpes Simplex |
1.5% |
Maternal Exposure Timing Unspecified |
1.5% |
Depression |
1.1% |
Epilepsy |
1.0% |
Squamous Cell Carcinoma |
1.0% |
Retroviral Infection |
0.8% |
Blood Pressure Increased |
0.7% |
Crohn's Disease |
0.7% |
Hiv Test |
0.7% |
Hypertension |
0.7% |
Psychotic Disorder |
0.7% |
Schizoaffective Disorder |
0.7% |
|
Drug Interaction |
28.1% |
Renal Failure Chronic |
10.1% |
Vomiting |
5.6% |
Oedema Peripheral |
4.5% |
Overdose |
4.5% |
Rash |
4.5% |
Renal Failure |
4.5% |
Renal Failure Acute |
4.5% |
Skin Exfoliation |
4.5% |
Visual Acuity Reduced |
4.5% |
Neuropathy Peripheral |
3.4% |
Pancytopenia |
3.4% |
Unevaluable Event |
3.4% |
Abnormal Weight Gain |
2.2% |
Cushing's Syndrome |
2.2% |
Foetal Exposure During Pregnancy |
2.2% |
Hepatic Enzyme Increased |
2.2% |
Torsade De Pointes |
2.2% |
Weight Increased |
2.2% |
Adverse Event |
1.1% |
|